Literature DB >> 7608441

Resource utilization in treatment of acute myocardial infarction: staff-model health maintenance organization versus fee-for-service hospitals. The MITI Investigators. Myocardial Infarction Triage and Intervention.

N R Every1, S D Fihn, C Maynard, J S Martin, W D Weaver.   

Abstract

OBJECTIVES: This study sought to compare the use of invasive procedures and length of stay for patients admitted with acute myocardial infarction to health maintenance organization (HMO) and fee-for-service hospitals.
BACKGROUND: The HMOs have reduced costs compared with fee-for-service systems by reducing discretionary admissions and decreasing hospital length of stay. It has not been established whether staff-model HMO hospitals also reduce the rate of procedure utilization.
METHODS: Using data from a retrospective cohort, we performed univariate and multivariate comparisons of the use of cardiac procedures, length of stay and hospital mortality in 998 patients admitted to two staff-model HMO hospitals and 7,036 patients admitted to 13 fee-for-service hospitals between January 1988 and December 1992.
RESULTS: The odds of undergoing coronary angiography were 1.5 times as great for patients admitted to fee-for-service hospitals than for those admitted to HMO hospitals (odds ratio 1.5, 95% confidence interval [CI] 1.3 to 1.9). Similarly, the odds of undergoing coronary revascularization were two times greater in fee-for-service hospitals (odds ratio 2.0, 95% CI 1.6 to 2.5). However, higher utilization was strongly associated with the greater availability of on-site cardiac catheterization facilities in fee-for-service hospitals. The length of hospital stay, by contrast, was approximately 1 day shorter in the fee-for-service cohort (7.3 vs. 8.0 days, p < 0.05).
CONCLUSIONS: Physicians in staff-model HMO hospitals use fewer invasive procedures and longer lengths of stay to treat patients with acute myocardial infarction than physicians in fee-for-service hospitals. This finding, however, appears to be associated with the lack of on-site catheterization facilities at HMO hospitals.

Entities:  

Mesh:

Year:  1995        PMID: 7608441     DOI: 10.1016/0735-1097(95)80013-7

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  7 in total

1.  Underuse of invasive procedures among Medicaid patients with acute myocardial infarction.

Authors:  E F Philbin; P A McCullough; T G DiSalvo; G W Dec; P L Jenkins; W D Weaver
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

2.  Managed care, vertical integration strategies and hospital performance.

Authors:  B B Wang; T T Wan; J Clement; J Begun
Journal:  Health Care Manag Sci       Date:  2001-09

Review 3.  Streptokinase. A pharmacoeconomic appraisal of its use in the management of acute myocardial infarction.

Authors:  J C Gillis; K L Goa
Journal:  Pharmacoeconomics       Date:  1996-09       Impact factor: 4.981

4.  Differences in discharge medication after acute myocardial infarction in patients with HMO and fee-for-service medical insurance.

Authors:  D McCormick; J H Gurwitz; J Savageau; J Yarzebski; J M Gore; R J Goldberg
Journal:  J Gen Intern Med       Date:  1999-02       Impact factor: 5.128

5.  An econometric approach to aggregating multiple cardiovascular outcomes in German hospitals.

Authors:  Angela Meggiolaro; Carl Rudolf Blankart; Tom Stargardt; Jonas Schreyögg
Journal:  Eur J Health Econ       Date:  2022-09-16

6.  Geography and service supply do not explain socioeconomic gradients in angiography use after acute myocardial infarction.

Authors:  David A Alter; C David Naylor; Peter C Austin; Benjamin T B Chan; Jack V Tu
Journal:  CMAJ       Date:  2003-02-04       Impact factor: 8.262

7.  Barriers to atrial fibrillation ablation during mitral valve surgery.

Authors:  J Hunter Mehaffey; Eric J Charles; Michaela Berens; Melissa J Clark; Chris Bond; Clifford E Fonner; Irving Kron; Annetine C Gelijns; Marissa A Miller; Eric Sarin; Matthew Romano; Richard Prager; Vinay Badhwar; Gorav Ailawadi
Journal:  J Thorac Cardiovasc Surg       Date:  2021-03-17       Impact factor: 6.439

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.